Puerarin mitigated LPS‐ATP or HG ‐primed endothelial cells damage and diabetes‐associated cardiovascular disease via ROS‐NLRP3 signalling
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Huizhen Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Tradi…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Reactive Oxygen Species, Isoflavones, Lipopolysaccharides. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Sailing Program, National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The occurrence and development of diabetic vascular diseases are closely linked to inflammation‐induced endothelial dysfunction. Puerarin (Pue), the primary component of Pueraria lobata , possesses potent anti‐inflammatory properties. However, its vasoprotective role remains elusive. Therefore, we investigated whether Pue can effectively protect against vascular damage induced by diabetes. In the study, Pue ameliorated lipopolysaccharide‐adenosine triphosphate (LPS‐ATP) or HG‐primed cytotoxicity and apoptosis, while inhibited reactive oxygen species (ROS)‐mediated NLR family pyrin domain containing 3 (NLRP3) inflammasome in HUVECs, as evidenced by significantly decreased ROS level, NOX4, Caspase‐1 activity and expression of NLRP3, GSDMD, cleaved caspase‐1, IL‐1β and IL‐18. Meanwhile, ROS inducer CoCI 2 efficiently weakened the effects of Pue against LPS‐ATP‐primed pyroptosis. In addition, NLRP3 knockdown notably enhanced Pue's ability to suppress pyroptosis in LPS‐ATP‐primed HUVECs, whereas overexpression of NLRP3 reversed the inhibitory effects of Pue. Furthermore, Pue inhibited the expression of ROS and NLRP3 inflammasome‐associated proteins on the aorta in type 2 diabetes mellitus rats. Our findings indicated that Pue might ameliorate LPS‐ATP or HG‐primed damage in HUVECs by inactivating the ROS‐NLRP3 signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Hairong Zeng
Förderung
- Shanghai Sailing Program
- National Natural Science Foundation of China
Zitieren
APA
Wei, H., Sun, M., Wang, R., Zeng, H., Zhao, B., & Jin, S. (2024). Puerarin mitigated LPS‐ATP or HG ‐primed endothelial cells damage and diabetes‐associated cardiovascular disease via ROS‐NLRP3 signalling. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18239
Vancouver
Wei H, Sun M, Wang R, Zeng H, Zhao B, Jin S. Puerarin mitigated LPS‐ATP or HG ‐primed endothelial cells damage and diabetes‐associated cardiovascular disease via ROS‐NLRP3 signalling. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18239
BibTeX
@article{Wei2024,
author = {Wei, Huizhen and Sun, Mengru and Wang, Ruixuan and Zeng, Hairong and Zhao, Bei and Jin, Shenyi},
title = {Puerarin mitigated LPS‐ATP or HG ‐primed endothelial cells damage and diabetes‐associated cardiovascular disease via ROS‐NLRP3 signalling},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18239}
}
EUVIMED